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Abstract: Resveratrol, a safe and multi-targeted agent, has been associated with suppression
of survival, proliferation and metastasis of cancer, however, the underlying mechanisms for its
anti-cancer activity, particularly on cellular signaling during cancer cell migration still remain poorly
understood. We investigated the invasion response of two human colorectal cancer (CRC) cells
(HCT116 and SW480) to resveratrol and studied the effect of specific pharmacological inhibitors,
cytochalasin D (CytD) and focal adhesion kinase-inhibitor (FAK-I) on FAK, cell viability and migration
in CRC. We found that resveratrol altered cell phenotype of both CRC cells, reduced cell viability
and the results were comparable to FAK-I and CytD. These effects of resveratrol were associated
with marked Sirt1 up-regulation, FAK down-regulation, inhibition of focal adhesion and potentiation
of effects by combinatorial treatment of resveratrol and inhibitors. Interestingly, inhibition of FAK
with FAK-I or treatment with CytD suppressed resveratrol-induced Sirt1 up-regulation and markedly
down-regulated FAK expression. Resveratrol or combination treatment with inhibitors significantly
activated caspase-3 and potentiated apoptosis. Moreover, resveratrol suppressed invasion and colony
forming capacity, cell proliferation, β1-Integrin expression and activation of FAK of cells in alginate
tumor microenvironment, similar to FAK-I or CytD. Finally, we demonstrated that resveratrol, FAK-I
or CytD inhibited activation of NF-κB, suppressed NF-κB-dependent gene end-products involved in
invasion, metastasis, and apoptosis; and these effects of resveratrol were potentiated by combination
treatment with FAK-I or CytD. Our data illustrated that the anti-invasion effect of resveratrol by
inhibition of FAK activity has a potential beneficial role in disease prevention and therapeutic
management of CRC.
Keywords: resveratrol; colorectal cancer; FAK; NF-κB; integrin; Sirt1
1. Introduction
As the third most prevalent cancer in the world, colorectal cancer affects more than half a million
people per annum [1] constituting about 10% of all estimated cancer deaths [2]. Although a long-term
decline in colorectal cancer death has been observed since the early 1980s, mainly related to enhanced
screening and improved treatment methods, colorectal cancer remains a clinical challenge as ~50%
of patients develop chemoresistance to current chemotherapeutic drugs, as well as recurrence and
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metastatic events [3,4]. The pathogenesis of colorectal cancer is regarded as a multi-step process,
orchestrated by multiple genetic mutations, epigenetic modifications and interaction with the tumor
microenvironment [5]. It is recognized that the interaction between the malignant tumor cells and their
surrounding microenvironment are important mediators that trigger tumor progression, invasion and
metastasis [6,7].
The Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase that is activated in response
to cell adhesion and transduces extracellular signals through tyrosine phosphorylation onto various
intracellular molecules in both growth factor dependent and adhesion-dependent manner [8]. FAK is
expressed in most tissues and cell types and is evolutionarily conserved in mammalian species as
well as lower eukaryotic organisms [9]. Indeed, the human FAK protein is structurally identical to
both mouse and chicken FAK and expresses 95–97% amino acid homology between these species,
suggesting a crucial function in cells [10].
FAK participates in integrin-mediated signaling functions, enabling the cell adhesion
signals that stimulate reorganization of the cytoskeleton and interaction of the cells with their
microenvironment [11,12]. Integrins are cell surface receptors mediating e cell adhesion to
the extracellular matrix, as well as dynamic signaling molecules facilitating cell migration as
it occurs in normal processes such as angiogenesis, wound healing, immune system function,
and development [13]. Indeed, integrin-mediated signaling is one of the strongest activators
of FAK [14]. Integrin receptor binding to extracellular matrix proteins results in the formation
of adhesomes where FAK localizes to a membrane-proximal signaling layer containing integrin
cytoplasmic tails and paxillin and FAK can function upstream of Src phosphorylation events [14].
It is well known that integrins act as bidirectional signaling transmitters linking the signaling
communication between the inside and the outside of the cells [15]. Aberrant expression and function
of integrins may contribute to many disease states including cancer [13]. In cancer, it has been observed
that integrin-mediated signaling via focal adhesion enables the reorganization of the cytoskeleton
and favors tumor progression, invasion and metastasis [15]. Aggregation of FAK with integrins and
cytoskeletal proteins in focal contacts leads to increased cell migration, as well as potential regulation
of cell proliferation and survival [16,17]. Additionally, in cancer, FAK has been shown to be involved
in cellular movement, invasion, survival, gene expression and cancer stem cell self-renewal [18].
Genetic tumor profiling has revealed both FAK DNA amplification (PTK2 gene at 8q24.3) and elevated
FAK mRNA levels in several cancers, including breast and ovarian carcinomas [19]. Indeed, activation
of FAK has been shown to be high in metastatic aggressive tumors and is correlated with poor clinical
outcome [8].
The plant-derived polyphenol, resveratrol (3,5,4′-trihydroxy-trans-stilbene), is found in more than
70 common plant species, including red grapes, cranberries, peanuts and root extracts of the weed
Polygonum cuspidatum [20–22]. Several reports have suggested that resveratrol modulates multiple
cellular signaling pathways through diverse mechanisms and thus is a promising multi-targeted agent
that can suppress cancer cell proliferation, metastasis, and induce apoptosis [23–26]. Moreover, it has
been previously reported that resveratrol inhibits IκB-kinase-β-mediated NF-κB activation and it
is a potent natural activator of Sirtuin-1 (Sirt1)—a nucleus related NAD+ histone deacetylase class
III [27–29]. Interestingly, previous reports from our laboratory have shown that resveratrol exerts its
inhibitory effects in colorectal cancer through its activity on diverse subcellular targets, including NF-κB
and Sirt1 and inhibition of epithelial-to-mesenchymal transition (EMT) markers with upregulation
of intercellular junctions and E-cadherin and the downregulation of NF-κB and vimentin [26,30].
Interestingly, the inhibition of EMT by resveratrol has been associated with modulation of integrin
activity [31]. Additionally, resveratrol has been shown to decrease the levels of cell adhesion proteins
and EMT associated mediator α5β1 integrin and hyaluronic acid in ovarian cancer cell lines [32].
Further, it was recently shown that resveratrol is able to inhibit phosphorylation of FAK in several cell
lines including the colon cancer cell line HT-29 [33–35].
Nutrients 2017, 9, 1073 3 of 22
In view of the above-mentioned findings, in the present study, we investigated the effect of
resveratrol on the regulation of colorectal cancer cell invasion and metastasis through modulation of
focal adhesion molecules and cancer cell motility.
2. Materials and Methods
2.1. Antibodies
Monoclonal anti-phospho-specific-FAK and anti-FAK antibodies were obtained from Becton
Dickinson (Heidelberg, Germany). Anti-Sirt1 and anti-CXCR4 (CXC-Motiv-Chemokinreceptor 4)
antibodies were purchased from Abcam PLC (Cambridge, UK). Anti-phospho-specific p65 (NF-κB)
and anti-phospho-specific p50 (NF-κB) antibodies were obtained from Cell Technology (Beverly,
MA, USA). Anti-active caspase 3, anti-MMP-9 and anti-MMP-13 antibodies were obtained from
R&D Systems (Heidelberg, Germany). Monoclonal anti-β1-Integrin and anti-β-actin antibodies were
purchased from Sigma-Aldrich Chemie (Munich, Germany). Monoclonal Anti-β-Actin antibody was
obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Alkaline phosphatase–linked sheep
anti-mouse and sheep anti-rabbit secondary antibodies for immunoblotting were purchased from
EMD Millipore (Schwalbach, Germany). Anti-Ki-67 and secondary antibodies used for fluorescence
labeling were obtained from Dianova (Hamburg, Germany). All antibodies were used at concentrations
recommended by the manufacturers.
2.2. Growth Media and Chemicals
Cell culture growth medium consisting of Dulbecco’s modified Eagle’s medium/Ham’s F-12 (1:1),
10% fetal bovine serum (FBS), 0.5% amphotericin B solution, 1% penicillin/streptomycin solution
(10,000 IU/10,000 IU), 75 µg/mL ascorbic acid, 1% essential amino acids and 1% glutamine was
obtained from Seromed (Munich, Germany). Epon was purchased from Plano (Marburg, Germany).
Alginate, cytochalasin D (CytD) and resveratrol with purity greater than 98% were purchased from
Sigma. A 100 mM stock solution of resveratrol (molecular weight 228.2) was prepared in ethanol
and further diluted in cell culture medium to prepare working concentrations. The maximum final
content of ethanol in cultures was less than 0.1% and this concentration was also used as a control.
CytD was dissolved in DMSO and further diluted in serum-starved medium to establish working
solutions. Hereby, final concentrations of DMSO did not exceed 0.1%. Focal adhesion kinase inhibitor
(PF-562271 and PF-573228) was purchased from Sellekchem (Munich, Germany). For the experiments,
a stock solution of 10 mM Focal adhesion kinase inhibitor (FAK-I) dissolved in DMSO was prepared
and further diluted in serum-starved medium to establish working solutions. All stock solutions were
stored as recommended by the manufacturers.
2.3. Cell Lines and Cell Culture
Human SW480 colorectal cancer (CRC) cells were purchased from the American Type Culture
Collection (ATCC, Manassas, VA, USA) and human HCT116 CRC cells were obtained from the
European Collection of Cell Cultures (Salisbury, UK). The cells were maintained in tissue culture flasks
in growth medium and in a humidified incubator at 37 ◦C in an atmosphere of 95% air and 5% CO2.
The medium was changed every three days, and cells were passaged at 80–90% confluency using
trypsin/EDTA.
2.4. Immunofluorescence and Light Microscopy Analysis of Monolayer Cultures
To examine the influence of FAK-inhibitor, CytD and resveratrol on HCT116 and SW480 CRC
cell phenotype and expression/activation of Sirt1, FAK, Ki-67, and caspase-3, light microscopic
investigations and immunofluorescence staining were performed. Cells were cultured on glass plates
to sub-confluency in monolayers and either left untreated, or were treated with 5 µM resveratrol,
with 10 µM FAK-I (PF-562271), with 0.1 µg/mL CytD or a combination of 5 µM resveratrol and either
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10 µM FAK-I (PF-562271) or 0.1 µg/mL CytD for 12 h. For immunofluorescent investigation, cells were
fixed with methanol, rinsed with PBS and incubated with bovine serum albumin (BSA) for 30 min.
Primary antibodies were diluted 1:50 in PBS/BSA, incubated overnight at 4 ◦C in a humidfied chamber,
washed three times with PBS/BSA followed by incubation with rhodamine-coupled secondary
antibodies for 1.5 h and finally washed again three times with aqua dest. Counter staining was
performed with DAPI (4,6-diamidino-2-phenylindole, Sigma) to visualize cell nuclei. Slides were
covered with fluoromount and examined under a fluorescent microscope (Leica, Darmstadt, Germany).
In FAK immunolabeled cultures the number of focal adhesion points was quantified by scoring
800–1000 cells from 10 different microscopic fields. One of three independent experiments is shown.
Values were compared to the control, and statistically significant values with p < 0.05 are designated
by an asterisk (
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microscope (Leica, Darmstadt, Germany). Quantification of apoptotic cells was performed by scoring
800–1000 cells from 10 different microscopic fields. Result from one of three independent experiments
is shown in figures. Values were compared to the control, and statistically significant values with
p < 0.05 are designated by an asterisk (
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2.6. Cell Proliferation Assay
The effect of FAK-inhibitor, CytD, resveratrol and their combination on the
proliferation and viability of HCT116 and SW480 CRC cells was determined by the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described
previously [36]. Briefly, the cells (5000 per well in triplicate in a 96-well plate) were treated
with either 5 µM resveratrol alone, different concentrations of CytD (0.1, 1, 2, and 4 µg/mL),
different concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 µM) each or co-treated with 5 µM
resveratrol and the indicated concentrations of either CytD or F K-I for 12 h. Subsequently, 100 µL of
modified cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS)
and 10 µL MTT solution (5 mg/mL) was added to each well and the plate was incubated for 4 h at
37 ◦C. Finally, 100 µL of the MTT solubilization solution (10% Triton X-100/acidic isopropanol) was
added per well, and the cells incubated overnight at 37 ◦C. Metabolically active cells were evaluated
by measuring the Optical Density at 550 nm (OD550) using a 96-well multi-scanner plate ELISA reader
(Bio-Rad Laboratories I c. Munich, Germany). Data were derived from at least three independent
experiments, and statistical analysis was done to obtain the final values.
2.7. Alginate Culture
A detailed description of cell cultivation in alginate culture has been previously described by our
group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) were resuspended in alginate
(2% in 0.15 M NaCl) and added dropwise into a 100 mM CaCl2 solution at ambient temperature (AT)
where the alginate beads polymerized after 10 min forming a round and stable bead. Subsequently,
the alginate beads were washed three times with 0.15 M NaCl solution and twice with serum-starved
medium (3% FBS) before starting treatment.
Nutrients 2017, 9, 1073 5 of 22
2.8. Invasion (Migration) Assay
To investigate invasion capacity, HCT116 and SW480 CRC cells were cultured in alginate
beads as described above. Cells were either left untreated, or treated with 5 µM resveratrol alone,
different concentrations of CytD (0.1, 1, and 2/mL), FAK-I (PF-562271: 0.01, 0.1, 1, and 10 µM)
individually or co-treated with 5 µM resveratrol and the indicated concentrations of either CytD
or FAK-I for 28 days. Invasive cells that migrated through the alginate beads and formed adhered
colonies on the bottom of the petri dish were fixed with Karnowsky fixative, stained with toluidine
blue for 5 min and carefully washed two times with PBS. The number of migrated and positively
stained adhered colonies were quantified and evaluated manually by counting all colonies under a
light microscope (Axioplan, Zeiss, Germany) and visualized. This assay was repeated every 3 to 4 days
until Day 28 of culture. The mean number of colonies in triplicate was calculated, which is reported in
each graph. Each experiment was repeated at least three times.
2.9. Western Blot Analysis
In another set of experiments, HCT116 and SW480 CRC cells were cultured in alginate beads as
described above and were either left untreated, or treated with 5 µM resveratrol alone, 0.1 µg/mL CytD,
10 µM FAK-I (PF-562271) or co-treated with 5 µM resveratrol and either the indicated concentration of
CytD or FAK-I for 10 days. Proteins were extracted from the alginate cultures with lysis buffer (50 mM
Tris-HCl, pH 7.2, 150 mM NaCl, 1% (v/v) Triton X-100, 1 mM sodium orthovanadate, 50 mM sodium
pyrophosphate, 100 mM sodium fluoride, 0.01% (v/v) aprotinin, 4 µg/mL of pepstatin A, 10 µg/mL of
leupeptin, 1 mM phenylmethylsulfonyl fluoride, PMSF) on ice for 30 min, as previously described [38]
and total protein concentration was measured with the bicinchonic acid assay system (Uptima,
Monlucon, France) using bovine serum albumin as a standard. Subsequently, samples were reduced
with 2-mercaptoethanol and equal quantities of protein (500 ng/lane), separated under reducing
conditions by SDS-PAGE and transferred onto nitrocellulose membranes using a transblot apparatus
(Bio-Rad). After pre-incubation in blocking buffer (5% skim milk powder in PBS, 0.1% Tween 20)
for 1 h, membranes were incubated with primary antibodies at 4 ◦C overnight, washed three times
with blocking buffer, and then further incubated with alkaline phosphatase-conjugated secondary
antibodies for 2 h at AT. After further washing in 0.1 M Tris, pH 9.5, containing 0.05 M MgCl2 and
0.1 M NaCl, specific antigen-antibody complexes were detected using nitro blue tetrazolium and
5-bromo-4-chloro-3-indoylphosphate (p-toluidine salt; Pierce). Specific β-actin antibody was used for
the internal control to normalize the sample amounts.
2.10. Statistical Analysis
All experiments were performed three times as individual experiments with three replicates.
For statistical analysis, a Wilcoxon–Mann–Whitney test was applied. Score values for image quality
and presence of artifacts were compared for each sequence.
Data were shown as mean values ± SD or SEM, and were compared by one-way or
two-way analysis of variance (ANOVA), if the normality test passed (Kolmogorov–Smirnov test).
Otherwise, the Kruskal–Wallis ANOVA on ranks was used. A p value of < 0.05 was considered to
establish statistically significant differences.
3. Results
The purpose of this study was to investigate the effect of resveratrol on regulating colorectal
cancer cell (CRC) invasion and metastasis through regulation of focal adhesion molecules. We used
two well-characterized colorectal cancer cell lines (HCT116 and SW480) in monolayer, as well as 3D
alginate tumor microenvironment culture to address this question. The concentration of ethanol or
DMSO applied in our study had no suppressive effect on CRC cell viability.
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3.1. Resveratrol Alters Phenotype of CRC Cells Similar to FAK-Inhibitor or Cytochalasin D
Since cytoskeletal remodeling is critical for cancer cell invasion and migration [8], we first
evaluated whether resveratrol alters colorectal cancer cell morphology cytoskeleton organization.
HCT116 and SW480 cells in monolayer cultures were left untreated, treated with 5 µM resveratrol,
with 10 µM FAK-I (PF-562271), with 0.1 µg/mL CytD alone, or a combination of 5 µM resveratrol
and either 10 µM FAK-I or 0.1 µg/mL CytD for 12 h. As shown in Figure 1, in HCT116 untreated
control, cultures evenly distributed cell colonies (arrows) with overall epithelial cell morphology
and close cell-to-cell contacts were observed (Figure 1A). In contrast to HCT116, untreated SW480
cells showed a more mesenchymal morphology, less colony formation and fewer tight cell-to-cell
contacts. The SW480 cells demonstrated a flattened shape and numerous microvilli-like cytoplasmic
processes (Figure 1G). However, in both cell lines treatment with resveratrol significantly increased
epithelial morphology, enhanced tight cell-to-cell contact and showed that most of the cells developed
rounded morphology (Figure 1B,H). In contrast, in both cell lines treatment with FAK-I or CytD led
to rounding of the cells and dissolution of the epithelial cell cluster with clear residues of adhesion
molecules visible. Furthermore, the remnants of adhesive contacts and many detached cells were
observed (Figure 1C,E,I,K). Combined treatment with resveratrol markedly increased the observed
effects of FAK-I or CytD mono-treatment in HCT116 and SW480 (Figure 1D,F,J,L). Specially, it was
observed that cells maintained attachment better than without resveratrol treatment and more cell
clusters were formed.
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or were treated with 5 μM resveratrol alone (B,H), 10 μM FAK-I (PF-562271) (C,I), 0.1 μg/mL CytD 
(E,K) or a combination of 5 μM resveratrol and either 10 μM FAK-I (PF-562271) (D,J) or 0.1 μg/mL 
CytD (F,L) for 12 h and images were captured with a light microscope as described in materials and 
methods. Magnification 400×; bar = 30 nm. 
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We next investigated the effects of FAK-I or CytD and/or resveratrol on cell viability by 
performing a MTT assay in HCT116 and SW480 cells (Figure 2). Serum-starved HCT116 and SW480 
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Figure 1. Effects of resveratrol and/or specific FAK-inhibitor and cytochalasin D on the phenotype of
CRC cells. HCT116 and SW480 cells were cultured in monolayer and either left untreated alone (A,G)
or were treated with 5 µM resveratrol alone (B,H), 10 µM FAK-I (PF-562271) (C,I), 0.1 µg/mL CytD
(E,K) or a combination of 5 µM resveratrol and either 10 µM FAK-I (PF-562271) (D,J) or 0.1 µg/mL
CytD (F,L) for 12 h and images were captured with a light microscope as described in materials and
methods. Magnification 400×; bar = 30 nm.
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3.2. Resveratrol Suppresses Cancer Cell Viability Similar to FAK-Inhibitor or Cytochalasin D
We next investigated the effects of FAK-I or CytD and/or resveratrol on cell viability by
performing a MTT assay in HCT116 and SW480 cells (Figure 2). Serum-starved HCT116 and SW480 in
monolayer culture were either left untreated, treated with 5 µM resveratrol or different concentrations
of CytD (0.1, 1, 2, and 4 µg/mL), different concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 µM)
alone or co-treated with 5 µM resveratrol and the indicated concentrations of either CytD or FAK-I
for 12 h. As shown for MTT results in Figure 2, cell viability in HCT116 was markedly reduced
by 42–50% with resveratrol treatment compared to controls (Figure 2A,B). Furthermore, significant
dose-dependent decreases of 23%, 77%, 91% and 95% in cell viability of HCT116 treated with 0.1, 1, 2
and 4 µg/mL CytD, were observed, respectively. Cell viability was further decreased by 62%, 78%,
90% and 97% in combination treatment of resveratrol and 0.1, 1, 2 and 4 µg/mL CytD, respectively
(Figure 2A). Treatment with FAK-I induced significant dose-dependent decreases of 4%, 21%, 71% and
77% in cell viability of HCT116 treated with 0.01, 0.1, 1 and 10 µM FAK-I, respectively (Figure 2B).
In SW480 cells, resveratrol treatment significantly reduced cell viability by 38–48% (Figure 2C,D).
Significant dose-dependent decreases of 51%, 81%, 84% and 90% in cell viability of SW480 treated
with 0.1, 1, 2 and 4 µg/mL CytD, respectively, were observed (Figure 2C). Cell viability in cells treated
with a combination of resveratrol and 0.1, 1, 2 and 4 µg/mL CytD significantly decreased to 60%, 81%,
85% and 93%, correspondingly (Figure 2C). Treatment with 0.01, 0.1, 1 and 10 µM FAK-I markedly
decreased cell viability of SW480 dose-dependent by 8%, 25%, 75% and 85%, respectively (Figure 2D).
Interestingly, it was noted that co-treatment with resveratrol and 0.01, 0.1, 1 and 10 µM FAK-I markedly
suppressed decrease of 51%, 61%, 86% and 96%, respectively, in cell viability of SW480 compared to
mono-FAK-I treatment (Figure 2D).
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SW480 (C,D) cell lines treated with resveratrol and/or different concentrations of CytD (0.1, 1, 2, and 
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3.3. Resveratrol-Induced Sirt1 Expression Is Mediated by Focal Adhesion Kinase and Cytoskeletal Proteins in 
CRC Cells Monolayer Culture as Revealed by Immunofluorescence Microscopy 
The histone deacetylase Sirt1 is a major subcellular target of resveratrol [39,40] and is a major 
target for resveratrol-mediated suppression of colorectal cancer cell growth and metastasis [30,41]. 
Therefore, we investigated the role of FAK or cytoskeletal organization on the resveratrol-induced 
up-regulation of Sirt1 expression (arrows) and of the possible associated mechanism in colorectal 
cancer cells. Serum-starved HCT116 and SW480 cultures were left untreated, treated with 5 μM 
eratrol and/ ific FAK-inhibitor and cytochal sin D on the proliferation of
CR cells. MTT ass y showed inhibition of cell pro ife at on and viability in HCT116 (A,B) and SW480
(C,D) cell lines treated with resveratrol and/or different conce trations of CytD (0.1, 1, 2, and 4 µg/mL)
or FAK-Inhibitor (PF-562271: 0.01, 0. , 1, and 10 µM) cultured in monolayer f r 12 h. Data shown
are representativ of thr e indep ndent sets of experiments. Values were compared with the control
and statistically significant values with p < 0.05 are designated by an asterisk (
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concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 μM) each or co-treated with 5 μM resveratrol 
and the indicated concentrations of either CytD or FAK-I for 12 h. Subsequently, 100 μL of modified 
cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was added to each well and the plate was incubated for 4 h at 37 °C. 
Finally, 100 μL of the MTT solubilization solution (10% Triton X-100/acidic isopropanol) was added 
per well, and the cells incubated overnight at 37 °C. Metabolically active cells were evaluated by 
measuring the Optical Density at 550 nm (OD550) using a 96-well multi-scanner plate ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data were derived from at least three independent 
experiments, and statistical analysis was done to obtain the final values. 
2.7. Alginate Culture  
A detailed description of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) were resuspended in 
alginate (2% in 0.15 M NaCl) and added dropwise into a 100 mM CaCl2 solution at ambient 
temperature (AT) where the alginate beads polymerized after 10 min forming a round and stable 
bead. Subsequently, the alginate beads were washed three times with 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion capacity, HCT116 and SW480 CRC cells were cultured in alginate beads 
as described above. Cells were either left untreated, or treated with 5 μM resveratrol alone, different 
) and p < 0.01 are
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investigation, cells were fixed with methanol, rinsed with PBS and incubated with v ne serum 
albumin (BSA) for 30 min. Primary antibodies were diluted 1:50 in PBS/BSA, incubat overnight at
4 °C in a humidfied chamber, washed three times with PBS/BSA followed by incubation with 
rhodamine-coupled secondary antibodies for 1.5 h and finally washed ag in th ee times aqua 
dest. Counter staining was performed with DAPI (4,6-diamidino-2-phenylindole, Sigma) to 
visualize cell nuclei. Slides were covered with fluoromount nd examined under a fluorescent 
microscope (Leica, Darmstadt, Germany). In F K immu olabeled cultures the number of focal 
adhesion points was quantified by scoring 800–1000 cells from 10 diff rent micro copic fields. One of 
three independent experiments is shown. Values were compar d to the control, and statistic lly 
significant values with p < 0.05 are design   an as  ( ); p < 0.01 by two asterisks ( ). 
2.5. DAPI Staining of Apoptotic Cells 
To examine the apoptotic changes induced by two different FAK inhibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC cells, DAPI (4,6-diamidino-2-phenylindole, Sigma) nuclear 
staining assay was performed. Cells were eeded on glass plates at 80–90% conflu ncy and treated 
with different concentrations of FAK-I (PF-562 71: 0.1, 1, 10, 20, and 50 μM; and PF-573228: 0.1, 1, 10, 
20, and 50 μM) for 12 h. After completion of treatment, he lls were fixed with met anol for 10 min, 
washed twice with PBS, and in ubated with DAPI solution for 10 min in the dark. Label d cells w re 
washed repeatedly with PBS to remove the excess DAPI sta n and evaluated under fluorescence 
microscope (Leica, Darmstadt, Germany). Quantification of apoptotic cells was performed by
scoring 800–1000 cells from 10 different microscopic fields. Result from one of thre  independent 
experiments is shown in figures. Values were compared to the control, and statistic lly significant 
values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by two asterisks ( ). 
2.6. Cell Proliferation Assay 
The effect of FAK-inhibitor, CytD, resveratrol and their combination on the proliferation and 
viability of HCT116 and SW480 CRC cells was determined by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptak  method as described 
previously [36]. Briefly, the cells (5000 per w ll in triplicat  in a 96-well plate) w re treat d with 
either 5 μM resveratrol alone, different concentrations of CytD (0.1, 1, 2, and 4 μg/mL), different 
concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 μM) each or co-tre ed with 5 μM resveratrol 
and the indicated concentrations of either CytD or FAK-I for 12 h. Subsequently, 100 μL of mo ified 
cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was added to each wel  and the plate was incubated for 4 h at 37 °C. 
Finally, 100 μL of the MTT solubilization solution (10% Triton X-100/acidic isopr panol) was added 
per well, and the cells incubated overnight at 37 °C. Me abolically active cells were evaluated by 
measuring the Optical Density at 550 nm (OD550) using a 96-well multi-scanner plat  ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data were derived from at least three independent 
experiments, and statistical analysis was done to obtain the final values. 
2.7. Alginate Culture  
A detailed description of cell cultivation in al inate culture has be n previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) were resuspended in 
alginate (2% in 0.15 M NaCl) and added dropwise into a 100 mM CaCl2 solution at ambient 
temperature (AT) where the alginate beads polymerized aft r 10 min forming a round and stabl  
bead. Subsequently, the alginate beads were washed ree times with 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion capacity, HCT116 n  SW480 CRC c lls were cultured in algi ate beads 
as described above. Cells were either left untreated, or treated with 5 μM resveratrol alone, different 
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investigation, cells w re fixed with methano , rinsed with PBS and incubated with bovine s rum 
albumin (BSA) for 30 min. Primary antibodies w re diluted 1:50 in PBS/BSA, incubated ov rnigh  at 
4 °C in a humidfied chamber, washed three times with PBS/BSA f llowed y ncubation with
rhodamine-coupled secondary antibodies for 1.5 h and finally washed gain three times with aqua 
dest. Counter stai ing was performed with DAPI (4,6-diam d no-2-phenylindole, S gma) to 
visualize cell nuclei. Slides w re cov red with flu romount and examined under a fluorescent 
microscope (Leica, Darmstadt, Germany). In FAK i munol beled cultures the number of f cal 
adhesion points was quantified by scoring 800–1 00 cells from 10 iff r nt micro c pic fields. On  of 
three ind pendent experiment  is sh w . V lues w re compared to the control, and sta stically 
significant values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by two asteri ks ( ). 
2.5. DAPI Stai ing of A optotic Cells 
To examine the a optoti  changes induced by two diff rent FAK inhibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC cell , DAPI (4,6-diam dino-2-phenylindole, Sigma) nuclear 
stai ing assay was performed. Cells w re se ed on gl ss plat s at 80–90% confluency and tr ated 
with diff rent concentrations of FAK-I (PF-562271: 0. , 10, 20, and 50 μM; and PF-573228: 0. , 10, 
20, and 50 μM) for 12 h. After completion of tre tmen , th  cells w re fixed with methanol for 10 min, 
washed twice with PBS, and incubated with DAPI solution for 0 mi in the dark. Lab led cells w re 
washed r peatedly with PBS to remove th  exce s DAPI stain and ev luated under fluorescen e 
microscope (Leica, Darmstadt, Germany). Qua tification of a optoti  cells was performed by 
scoring 800–1 00 cells from 10 diff rent microscopic fields. Result from one of three ind pendent 
experiment is shown in figures. Values w re compared to the control, and sta stically s gnificant 
values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by two asteri ks ( ). 
2.6. Cell Proliferation Assay 
The ffect of FAK-inhibitor, CytD, resver trol and their combination on the proliferation and 
viability of HCT116 and SW480 CRC cells was determined by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described 
previously [36]. Briefly, the cells (5 00 per well in triplicate in a 96-well plate) w re treated with
either 5 μM resveratrol alone, diff rent con e trations of CytD (0. , 1, 2, and 4 μg/mL), diff rent 
concentrations of FAK-I (PF-562271: 0.01, 0. 1, and 10 μM) each or co-treated with 5 μM resveratrol 
and the indicated concentrations of either CytD or FAK-I for 12 h. Subsequently, 100 μL of modified 
cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was ad ed to each well and the plate was inc ated for 4 h at 37 °C. 
Finally, 100 μL of the MTT solubilization solution (10% Tri on X-100/ac d c isopropanol) was ad ed 
per well, and the cells incubated overnight at 37 °C. Metabolical y active cells w r evaluated by
measuring the Optical Density at 550 nm (OD550) using a 96-well multi-sca ner plate ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data w re derived from at least three i d pendent 
experiments, and sta stic l nalysis was done to obtain the final values. 
2.7. Alginate C lture  
A detaile  description of cell cultivation in alginate culture has been previously escribed by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) w re re uspen ed in 
alginate (2% in 0.15 M NaCl) and ad e  dro wise into a 100 mM Cl2 solution at ambient 
temperature (AT) wh re the alginate beads polymeriz d after 10 min forming  round and table 
bead. Subsequently, the alginate beads w re washed th ee times with 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion c pacity, HCT116 and SW480 CRC cells w re cul ured in algin t  beads 
as described above. Cells w re either left untreated, o  treated with 5 μM resveratro  alone, diff rent 
).
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3.3. Resveratrol-Induced Sirt1 Expression Is Mediated by Focal Adhesion Kinase and Cytoskeletal Proteins in
CRC Cells Monolayer Culture as Revealed by Immunofluorescence Microscopy
The histone deacetylase Sirt1 is a major subcellular target of resveratrol [39,40] and is a major
target for resveratrol-mediated suppression of colorectal cancer cell growth and metastasis [30,41].
Therefore, we investigated the role of FAK or cytoskeletal organization on the resveratrol-induced
up-regulation of Sirt1 expression (arrows) and of the possible associated mechanism in colorectal
cancer cells. Serum-starved HCT116 and SW480 cultures were left untreated, treated with 5 µM
resveratrol or treated with resveratrol (5 µM), and co-treated with 10 µM FAK-I (PF-562271) or with
0.1 µg/mL CytD for 12 h and subjected to immunofluorescence labeling with primary antibodies for
Sirt1 and rhodamine-coupled secondary antibodies. Counterstaining was performed with DAPI
to visualize the cell nuclei. As shown in Figure 3B, resveratrol alone significantly upregulated
the expression of Sirt1 protein and nuclear localization compared to the controls (Figure 3A).
However, the resveratrol-induced expression of Sirt1 protein in the nuclei of HCT116 was significantly
decreased by incubation with FAK-I and CytD (Figure 3C,D), indicating that FAK and cytoskeletal
signaling proteins, at least in part, are some of the main target proteins of resveratrol during the
resveratrol-induced anti-tumor effect in CRC cells.
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Figure 3. Effects of resveratrol and/or specific FAK-inhibitor and cytochalasin D on the Sirt1 
expression of CRC cells. Serum-starved HCT116 cells were cultured on glass plates in monolayer and 
either left untreated alone (A), or were treated with 5 μM resveratrol alone (B), or a combination of 5 
μM resveratrol and either 10 μM FAK-I (PF-562271) (C) or 0.1 μg/mL CytD (D) for 12 h and subjected 
to immunofluorescent labeling with anti-Sirt1 and nuclear counterstaining with DAPI. Magnification 
400×; bar = 30 nm 
3.4. Resveratrol-Induced Formation of Focal Adhesions in CRC Cells Are Inhibited by FAK-Inhibitor or 
Cytochalasin D  
FAK has been shown to be involved in cancer cell survival and invasion [18] and on the other 
hand resveratrol has been shown to suppress cancer cell migration/invasion [26] and inhibition of 
phosphorylation of FAK in pancreatic cancer [33–35]. To examine the effects of resveratrol on the 
FAK expression in colorectal cancer cells, serum-starved HCT116 cultures were treated as described 
above and subjected to immunolabeling with anti-FAK. Strong staining for FAK was observed in 
untreated controls in HCT116 (Figure 4). In control cell cultures, a distribution of FAK positive 
labeled focal adhesion points (arrows) was observed on the cytoplasmic membranes (Figure 4I(A), 
arrows and inset). Contrary to this, resveratrol reduced FAK labeling to a basal level, but 
interestingly, induced formation of focal adhesion clusters, which were strongly positively stained 
for FAK (Figure 4I(B), arrows and inset). The combination treatment with resveratrol and with 
FAK-I or CytD markedly reduced FAK staining in both HCT116 (Figure 4I(C)). Quantification of 
focal adhesion points confirmed that resveratrol, FAK-I, CytD or combination treatment markedly 
decreased the number of focal adhesion clusters compared to untreated control cultures in HCT116 
(Figure 4II). 
i r 3. Effects of resveratrol and/or specific FAK-inhibitor and cytochalasin D on the Sirt1 expression
of CRC cells. Serum-starved HCT116 cells were cultured on glass plates in monolayer and either
left untreated alone (A), or were treated with 5 µM resveratrol alone ( ), or a combination of
5 µM resveratrol and either 10 µM FAK-I (PF-562271) (C) or 0.1 µg/mL CytD (D) for 12 h and
subjected to immunofluorescent labeling with anti-Sirt1 and nuclear counterstaining with DAPI.
Magnification 400×; bar = 30 nm
-I ibitor or
Cytochalasin D
FAK has been sho n to be involved in cancer cell survival and invasion [18] and on the other
hand resveratrol has been sho n to suppress cancer cell igration/invasion [26] and inhibition of
phosphorylation of FAK in pancreatic cancer [33–35]. To examine the effects of resveratrol on the FAK
expression in colorectal cancer cells, serum-starved HCT116 cultures were treated as described above
and subjected to immunolabeling with anti-FAK. Strong staining for FAK was observed in untreated
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controls in HCT116 (Figure 4). In control cell cultures, a distribution of FAK positive labeled focal
adhesion points (arrows) was observed on the cytoplasmic membranes (Figure 4I(A), arrows and
inset). Contrary to this, resveratrol reduced FAK labeling to a basal level, but interestingly, induced
formation of focal adhesion clusters, which were strongly positively stained for FAK (Figure 4I(B),
arrows and inset). The combination treatment with resveratrol and with FAK-I or CytD markedly
reduced FAK staining in both HCT116 (Figure 4I(C)). Quantification of focal adhesion points confirmed
that resveratrol, FAK-I, CytD or combination treatment markedly decreased the number of focal
adhesion clusters compared to untreated control cultures in HCT116 (Figure 4II).Nutrients 2017, 9, 1073 9 of 21 
 
 
Figure 4. Effects of resveratrol and/or specific FAK-inhibitor and cytochalasin D on the focal 
adhesion clusters of CRC cells. (I) Serum-starved HCT116 were either left untreated (IA,II), were 
treated with 5 μM resveratrol alone (IB,II), 10 μM FAK-I (PF-562271) (II), 0.1 μg/mL CytD (II) or a 
combination of 5 μM resveratrol and either 10 μM FAK-I (PF-562271) (IC,II) or 0.1 μg/mL CytD 
(ID,II) for 12 h. Immunofluorescent labeling with antibodies against FAK and counterstaining with 
DAPI to visualize cell nuclei was performed on HCT116 cells in monolayer. (II) To quantify the 
amount of focal adhesion, 800–1000 cells from 10 microscopic fields were counted. The examination 
was performed in triplicate, and the results are provided as the mean values with S.D. from three 
independent experiments. Values were compared with the control and statistically significant values 
with p < 0.05 are designated by an asterisk ( ) and p < 0.01 are designated by two asterisks ( ). 
Magnification 400×; bar = 30 nm 
3.5. Specific Inhibitors against FAK Lead to Increased Apoptosis in CRC Cells  
To investigate the effects of two different FAK inhibitors (PF-562271 and PF-573228) on the 
growth rate inhibition and the levels of apoptosis on colorectal cancer cells, HCT116 and SW480 
were treated with different concentrations of FAK-I (0.1, 1, 10, 20 and 50 μM) for 12 h and a nuclear 
staining assay with DAPI (4, 6-Diamidino-2-phenylindole, Sigma) was performed. This 
fluorescence-based staining method reveals apoptotic bodies containing nuclear fragmentation and 
chromatin condensation in apoptotic cells. The number of apoptotic nuclei was quantified by scoring 
800–1000 cells from 10 different microscopic fields. As shown in Figure 5, the number of apoptotic 
nuclei in control cultures of both HCT116 and SW480 ranged from 8–15%. The number of apoptotic 
nuclei markedly increased in both cell lines by FAK inhibitor treatment. A significant 
dose-dependent effect was observed in HCT116 treated with 0.1, 1, 10, 20 and 50 μM PF-562271 with 
an apoptotic increase of 23%, 39%, 46%, 82% and 98%, as well as with 0.1, 1, 10, 20 and 50 μM 
PF-573228 with an apoptotic increase of 30%, 38%, 41%, 79% and 96%, respectively (Figure 5A). In 
i r . Ef ects of resverat ol and/or specific FAK-inhibitor and cytochalasin D on the f cal adhesion
clusters of CRC cells. (I) Serum-starved HCT116 were either left un reated (IA,II), were treated with
5 µM resveratrol alone (IB,II), 10 µM FAK-I (PF-562271) (II), 0.1 µg/mL CytD (II) or a combination
of 5 µM resveratrol and either 10 µM FAK-I (PF-562271) (IC,II) or 0.1 µg/mL CytD (ID,II) for 12 h.
Immun fluorescent labeling with antibod es against FAK and cou terstaining with DAPI to visualize
cell nuclei was performed on HCT116 cells in m olayer. (II) To quantify the amount of focal adhesion,
800–1000 cells from 10 microscopic field were counted. The examination was perform d in tr plicate,
and the results are provided as mean values w th S.D. fro three independent experiments.
Values w re compared with the control and st tistically significant values with p < 0.05 are designat d
by an asterisk (
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investigation, cells were fixed with methanol, rinsed with PBS and incubated with bovine serum 
albumin (BSA) for 30 min. Primary antibodies were diluted 1:50 in PBS/BSA, incubated overnight at 
4 °C in a humidfied chamber, washed three times with PBS/BSA followed by incubation with 
rhodamine-coupled secondary antibodies for 1.5 h and finally washed again three times with aqua 
dest. Counter staining was performed with DAPI (4,6-diamidino-2-phenylindole, Sigma) to 
visualize cell nuclei. Slides were covered with fluoromount and examined under a fluorescent 
microscope (Leica, Darmstadt, Germany). In FAK immunolabeled cultures the number of focal 
adhesion points was quantified by scoring 800–1000 cells from 10 different microscopic fields. One of 
three independent experiments is shown. Values w re compared to e control,  statistically 
significant values with p < 0.05 are designated by an asterisk ( ); p < 0.01  two asterisks ( ).
2.5. DAPI Staining of Apoptotic Cells 
To examine the apoptotic changes induced by two different FAK inhibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC cells, DAPI (4,6-diamidino-2-phenylind le, Sigma) nuclear 
staining assay was performed. Cells were seeded on glass pla es at 80–90% confluency and treated 
with different concentrations of FAK-I (PF-562271: 0.1, 1, 10, 20, and 50 μM; a d PF-573228: 0.1, 1, 10
20, and 50 μM) for 12 h. After completion of treatment, the cells were fixed with methanol for 10 min, 
washed twice with PBS, and incubated with DAPI solution for 10 min in the dark. Labeled cells were 
washed repeatedly with PBS to remove the excess DAPI stain a d evaluated under fluorescence 
microscope (Leica, Darmstadt, Germany). Quantifi ation of apoptotic cells was er ormed by 
scoring 800–1000 cells from 10 different microscopi  fields. Result from one of three independent 
experiments is shown in figures. Values were compared to the ontrol, and sta isti a y significant 
values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by t o asterisks ( ). 
2.6. Cell Proliferation Assay 
The effect of FAK-inhibitor, CytD, resveratrol and their combination on the proliferation and 
viability of HCT116 and SW480 CRC cells was determined by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described 
previously [36]. Briefly, the cells (5000 per well in triplicate in a 96-well plate) were treated with 
either 5 μM resveratrol alone, different concentrations of CytD (0.1, 1, 2, and 4 μg/mL), different 
concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 μM) each or co-treated with 5 μM resveratrol 
and the indicated concentrations of either CytD or FAK-I for 12 h. Subsequently, 100 μL of modified 
cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was added to each well and the plate was incubated for 4 h at 37 °C. 
Finally, 100 μL of the MTT solubilization solution (10% Triton X-100/acidic isopropanol) was added 
per well, and the cells incubated overnight at 37 °C. Metabolically active cells were evaluated by 
measuring the Optical Density at 550 nm (OD550) using a 96-well multi-scanner plate ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data were derived from at least three independent 
experiments, and statistical analysis was done to obtain the final values. 
2.7. Alginate Culture  
A detailed description of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) were resuspended in 
alginate (2% in 0.15 M NaCl) and added dropwise into a 100 mM CaCl2 solution at ambient 
temperature (AT) where the alginate beads polymerized after 10 min forming a round and stable 
bead. Subsequently, the alginate beads were washed three times with 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion capacity, HCT116 and SW480 CRC cells were cultured in alginate beads 
as described above. Cells were either left untreated, or treated with 5 μM resveratrol alone, different 
) and p < 0.01 are designated by two asterisks (
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i vestigation, cells were fixed with methanol, rinsed with PBS and incubated with bovine serum 
albumin (BSA) for 30 min. Primary anti odies were diluted 1:50 in PBS/BSA, incubated overnight at 
4 °C in a humidfied chamber, ashed three mes with PBS/BSA followed by incubation with 
rhodamine-coupled secondary ntibodi s for 1.5 h and finally washed again three times with aqua 
des . Counter staining was performe  with DAPI (4,6-diamidino-2-phenylindole, Sigma) to 
visualize cell nuclei. Slid s were covered with fluoromount and examined under a fluorescent 
microscope (Leica, Darmstadt, Germany). In FAK immunol beled cultures the number of focal 
adhesio  points wa  quantifie  by c ring 800–1000 cells rom 10 different microscopic fields. One of 
three i endent experiments is hown. Valu s ere compared to the control, nd statis ically 
signific t value with p < 0.05 are designated   ast  ( ); p < 0.01 o asterisks ( ). 
2.5. DAPI Staining of Apoptotic Cells 
To examine th  apoptotic c anges induced by two different FAK inhibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC cells, DAPI (4,6-diamidino-2 phenylindole, Sigma) nuclear 
staining assay was p rformed. Cells wer seede  on glass plates at 80–90% confluency and treated 
with diff rent concentratio s of FAK-I (PF-56 271: 0. , , 10, 20, and 50 μM; and PF-573228: 0.1, 1, 10, 
20, a d 50 μM) for 12 h. After completion of treatment, the cells w re fixed with methanol for 10 min, 
washed twi  with PBS, a d incubated with DAPI s lution for 10 min in the dark. Labeled cells were 
washed repeate ly w th PBS t  remove the exces  DAPI stain and evaluated under fluorescence 
microscope (Leica, Darmstadt, Germany). Quantification of apoptotic cells was performed by 
scoring 800–1000 el  from 10 different microscopic fields. Result from one of three independent 
experiments is show  in figures. Value  w re compared to the control, and statistically signif cant 
values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by two asterisks ( ). 
2.6. Cell Proliferatio  Assay 
The effect of FAK-inhibitor, Cy D, resveratrol and their combination on the proliferation and 
viability of HCT116 and SW480 CRC cells was determined by the 
3-(4,5-di ethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described 
previously [36]. Briefly, the c lls (5000 p  well in triplicate in a 96-well plate) were treated with 
either 5 μM resveratrol alone, different concentrations of CytD (0.1, 1, 2, and 4 μg/mL), different 
concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 μM) each or co-treated with 5 μM resveratrol 
and the indicated concentrations of either CytD or FAK-I for 12 h. Subsequently, 100 μL of modified 
ce l culture medium (DMEM with ut phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT so ution (5 mg/mL) was added to each well and the plate was incubated for 4 h at 37 °C. 
Finally, 10  μL of the MTT solubilizati n solution (10% Triton X-100/acidic isopropanol) was added 
per well, and the cells incubated overnight at 37 °C. Metabolically active cells were evaluated by 
measuring the Optica  Density t 550 nm (OD550) using a 96-well multi-scanner plate ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data were derived from at least three independent 
experiments, and statistical analysis was done to obtain the final values. 
2.7. Alginate Culture  
A detailed desc iption of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) were resuspended in 
alginate (2% in 0.15 M NaCl) and added dropwise into a 100 mM CaCl2 solution at ambient 
temperatu e (AT) where the alginate beads polymerized after 10 min forming a round and stable 
bead. Subsequently, the alginate beads were washed three times with 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion capaci y, HCT116 and SW480 CRC cells were cultured in alginate beads 
as described above. Cells were either left untreated, or treated with 5 μM resveratrol alone, different 
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investigation, cells w re fixed with methanol, rinsed with PBS and incubated with bovine serum 
albumin (BSA) for 30 min. Primary antibodies w re diluted 1:50 in PBS/BSA, incubated overnight at 
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visualize cell nuclei. Slides w re cov red with flu romount and examined under a fluorescent 
microscope (Leica, Darmstadt, Germany). In FAK i munolabeled cultures the nu ber of focal 
adhesion points was quant fi  by scoring 800–1 00 cells from 10 diff re t microscopic fields. One of 
thre  ind pend nt exp riments is shown. Values w r  compare  to the control, and st stically 
signif cant values with p < . 5 designated by an asteri k ( ); p < 0.01 by two asteri ks ( ). 
2.5. DAPI Stai ing of A optotic Cells 
To examine th  a op oti  changes induced by two diff rent FAK inhibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC c lls, DAPI (4,6-d am dino-2-phenylindole, Sigma) nuclear 
stai ing assay w s performed. Cells were se ded on glass plates t 80–90% confluency and treated 
with diff rent conce t ations of FAK-I (PF-56227 : 0. , 10, 20, and 50 μM; and PF-573228: 0. , 10, 
20, a d 50 μM) for 12 h. After completion of treatment, the cells w re fixed with methanol for 10 m n, 
washed tw ce with PBS, and incubated with DAPI solution for 10 mi  in the d rk. Labeled cells w re 
washed r peat dly with PBS to remove t  excess DAPI stain a d evalu ted u der fluoresce ce 
microscope (Leica, Darmstad , Germany). Quantificati n of a op oti  cells was performed by 
sc ring 800–1 00 cells fr m 10 diff rent microscopic fields. Result from on of thr e ind pendent 
exp riment is shown in figures. Values w re compared to the con rol, and sta stically significant 
values with p < .05 are designated by an asterisk ( ); p < 0. 1 by two asteri ks ( ). 
2.6. Cell Prolifer tion Assay 
Th  effect of FAK-inh bitor, CytD, resveratrol an  their combination on the proliferation and 
viability of HCT116 and SW480 CRC cells was determined by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described 
previously [36]. Briefly, the cells (5 00 per well in triplicate in a 96-well plate) w re treated with 
either 5 μM resveratrol alone, diff rent concentratio s of CytD (0. , 1, 2, and 4 μg/mL), diff rent 
concentrations of FAK-I (PF-562271: 0.01, 0. 1, and 10 μM) each or co-treated with 5 μM resveratrol 
and the indicated concentrations of either CytD r FAK-I for 12 h. Subsequently, 100 μL of modified 
cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was ad ed to each well and the plate was incubated for 4 h at 37 °C. 
Finally, 100 μL f the MTT solubilizatio  solution (10% Triton X-100/ac d c isopropanol) was ad ed 
per well, and the cel s in ubated overnight t 37 °C. Metabolically active cells w r  evaluated by 
meas ring the Optical Density at 550 nm (OD550) using a 96-well multi-scanner plate ELISA reader 
(Bio-Rad Laboratori s Inc. Munich, Germa y). D ta w re derived from at least three ind pendent 
experime ts, and sta stic l nalysis was done t  obtain the final values. 
2.7. Alginate Culture  
A detaile  description of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) w re re uspen ed in 
alginate (2% in 0. 5 M Na l) and ad e  dropw se into a 100 mM CaCl2 solution at ambient 
temperature (AT) wh re the alginate beads polymerized after 10 min forming a round and stable 
bead. Subsequ ntly, the alginate beads w re washed three times with 0.15 M NaCl solution and 
twice with serum-s arved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion c pacity, HCT116 and SW480 CRC cells w re cultured in alginate beads 
as d scribed bove. Cells w re either left untreated, o  reated with 5 μM resveratro  alone, diff rent 
). M gnification 400×; bar = 30 nm.
3.5. Specific I hibitors against FAK Lead to Increased Apoptosis in CRC Cells
To investigate the effects of two differe t FAK inhibitors (PF-562271 and PF-573228) on the growth
rate inhibitio and the levels of apoptosis on colorectal cancer cells, HCT116 and SW480 were treat d
with differ nt concentrations of FAK-I (0.1, 1, 10, 20 d 50 µM) for 12 h and a nuclear stai ing assay
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with DAPI (4, 6-Diamidino-2-phenylindole, Sigma) was performed. This fluorescence-based staining
method reveals apoptotic bodies containing nuclear fragmentation and chromatin condensation
in apoptotic cells. The number of apoptotic nuclei was quantified by scoring 800–1000 cells from
10 different microscopic fields. As shown in Figure 5, the number of apoptotic nuclei in control cultures
of both HCT116 and SW480 ranged from 8–15%. The number of apoptotic nuclei markedly increased
in both cell lines by FAK inhibitor treatment. A significant dose-dependent effect was observed in
HCT116 treated with 0.1, 1, 10, 20 and 50 µM PF-562271 with an apoptotic increase of 23%, 39%, 46%,
82% and 98%, as well as with 0.1, 1, 10, 20 and 50 µM PF-573228 with an apoptotic increase of 30%,
38%, 41%, 79% and 96%, respectively (Figure 5A). In SW480 cells, a low concentration of 0.1 µM
PF-562271 or PF-573228 resulted in 15% and 13% apoptotic cells, respectively, similar to untreated
controls. Contrary to this, a significant dose-dependent increase in apoptosis was observed in SW480
cells treated with 1, 10, 20 and 50 µM PF-562271 with an apoptotic increase of 40%, 69%, 97% and
100%, as well as with 1, 10, 20 and 50 µM PF-573228 with an apoptotic increase of 38%, 65%, 95% and
100%, respectively (Figure 5B). These results demonstrate that FAK-I shows similar levels of apoptotic
induction in both cell lines.
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res lts demonstrate that FAK-I shows similar levels of apoptotic induction in both cell lines.  
 
Figure 5. Effects of specific FAK-inhibitors (PF-562271 and PF-573228) on the apoptosis of CRC cells. 
Serum-starved HCT116 (A) and SW480 (B) were treated with different concentrations of 
FAK-inhibitors (PF-562271, PF-573228: 0, 0.1, 1, 10, 20 and 50 μM) for 12 h. Monolayer cultures were 
fixed with methanol and nuclear staining assay (DAPI) was performed to reveal nuclear apoptotic 
changes. Quantification of apoptotic cells was performed by scoring 800–1000 cells from 10 different 
microscopic fields. One of three independent experiments is shown. Values were compared to the 
control and statistically-significant values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by 
two asterisks ( ). 
3.6. Resveratrol Potentiates FAK-Inhibitor- and Cytochalasin D-Induced Activation of Caspase-3 in CRC Cells 
Monolayer Culture as Revealed by Immunofluorescence Microscopy 
To examine the mechanisms by which resveratrol and/or FAK-I or CytD inhibit cell viability 
and induce apoptosis of CRC cells, we analyzed and compared their effect on the rate of the 
activation levels of caspase-3, which induces the apoptotic pathway in cells [42,43]. Therefore, the 
amount of apoptosis induced by resveratrol, FAK-I, CytD and their combined treatment in HCT116 
(Figure 6I) was confirmed by investigating the activation of caspase-3 with immunofluorescent 
labeling and induction of morphological nuclear changes with DAPI nuclear staining (arrows) 
(Figure 6II). In untreated control cultures of HCT116 (Figure 6I(A)) only small amounts of caspase-3 
positive stained cells (arrows) could be detected. In contrast to this, treatment with resveratrol, 
markedly induced caspase-3 expression in colorectal cancer cells (Figure 6I(B)). Interestingly, a 
significant increase of caspase-3 was observed in the combined treatment of resveratrol with either 
FAK-I or CytD (Figure 6I(C,D)). 
Apoptosis induction by caspase-3 activation was confirmed by examining morphological 
nuclear changes indicative of apoptosis with DAPI nuclear staining (Figure 6II). The number of 
apoptotic nuclei was quantified by scoring 800–1000 cells from 10 different microscopic fields. 
i r . Effects of specific FAK-inhibitors (PF-562271 and PF-573228) on the apopt sis of CRC
c lls. Serum-starved HCT116 (A) and SW480 (B) were treated with different c centrations f
- , PF-573 28: 0, 0.1, , 10, 20 and 50 µM) for 12 h. Monolayer cultures
were fixed with methanol and nuclear staining ssay (DAPI) was performed to reveal nuclear
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investigation, cells were fixed with methanol, rinsed with PBS and incubated with bovine serum 
albumin (BSA) for 30 min. Primary antibodies were diluted 1:50 in PBS/BSA, incubated overnight at 
4 °C in a humidfied chamber, washed three times with PBS/BSA followed by incubation with 
rhodamine-coupled secondary antibodies for 1.5 h and finally washed again three times with aqua 
dest. Counter staining was performe  it  DAPI (4,6-diamidino-2-phenylindole, Sigma) to 
visualize cell nuclei. Slides were covered with fluoromount and examined under a fluorescent 
microscope (Leica, Darmstadt, Germany). In FAK immu olabeled cul ures the number of focal 
adhesi n ints was quantified by scoring 800–1 00 cells from 10 differ nt microscopic fields. One of 
three indep ndent xp riments is shown. Values were compared to the control, and statistically 
significa t v lues with p < 0.05 are d signated by an aste ); p < 0.01 by two asterisks ( ). 
2.5. DAPI Staining of Apoptotic Cells 
To examine the apoptotic changes induced by two different FAK inhibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC cells, DAPI (4,6-diamidino-2-phenylindole, Sigma) nuclear 
staining a say was performed. Cells were seeded n glass plates at 80–90% confluency and treated 
with different concentrations of FAK-I (PF-562271: 0.1, 1, 10, 20, and 50 μM; and PF-573228: 0.1, 1, 10, 
20, and 50 μM) for 12 h. After com letion of tre tment, the cells were fixed wit  methanol for 10 min, 
washed twice with PBS, and incubated with DAPI solution for 10 min in the dark. Labeled cells were 
washed repeat dly with PBS to rem ve the excess DAPI stain a d evaluated under fluorescence 
micr scope (Leica, Darmstadt, Germany). Quantification of poptotic cell  was performed by 
scoring 800–1000 c lls from 0 different microscopic fields. Result from on  of three independent 
experiments is shown in figures. Values were compared to the control, and statistically significant 
value  with  < 0.05 are designated by an ast ri k ( ); p < 0.01 by two asterisks ( ). 
2.6. Cell Proliferation Assay 
The effect of FAK-inhibitor, CytD, resveratrol and their combination on the proliferation and 
viability of HCT116 and SW480 CRC cells was determined by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described 
previously [36]. Briefly, the cells (5000 per well in triplicate in a 96-well plate) were treated with 
either 5 μM resveratrol alone, different concentrations of CytD (0.1, 1, 2, and 4 μg/mL), different 
concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 μM) each or co-treated with 5 μM resveratrol 
and the indicated concentrations of either CytD or FAK-I for 12 h. Subsequently, 100 μL of modified 
cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was added to each well and the plate was incubated for 4 h at 37 °C. 
Finally, 100 μL of the MTT solubilization solution (10% Triton X-100/acidic isopropanol) was added 
per well, and the cells incubated overnight at 37 °C. Metabolically active cells were evaluated by 
measuring the Optical Density at 550 nm (OD550) using a 96-well multi-scanner plate ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data were derived from at least three independent 
experiments, and statistical analysis was done to obtain the final values. 
2.7. Alginate Culture  
A detailed description of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) were resuspended in 
alginate (2% in 0.15 M NaCl) and added dropwise into a 100 mM CaCl2 solution at ambient 
temperature (AT) where the alginate beads polymerized after 10 min forming a round and stable 
bead. Subsequently, the alginate beads were washed three times with 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion capacity, HCT116 and SW480 CRC cells were cultured in alginate beads 
as described above. Cells were either left untreated, or treated with 5 μM resveratrol alone, different 
);
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investigation, cells were fixed with methanol, rinsed with PBS and incubated with bovine serum 
albumin (BSA) for 30 min. Primary antibodies were diluted 1:50 in PBS/BSA, incubated overnight at 
4 °C in a humidfied chamber, washed three times with PBS/BSA followed by incubation with 
rhodamine-coupled secondary antibodies for 1.5 h and finally washed again three times ith aqua 
dest. Counter staining was performed with DAPI (4,6-diamidino-2-phenylindole, Sigma) to 
visualize cell nuclei. Slides were covered with fluoromount d examin d under  fluorescent 
microscope (Leica, Darmstadt, Germany). In FAK immunolabeled cultures the number of focal 
adhesion points was quantified by scoring 800–1000 cells from 10 diff rent microsco ic fields. One of 
three independent experiments is shown. Values were compared to the control, and statistically 
significant values with p < 0.05 are designated by an ast  ( ); p < 0.01 by two asterisks ( ). 
2.5. DAPI Staining of Apoptotic Cells 
To examine the apoptotic changes induced by two different FAK inhibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC cells, DAPI (4,6-diamidino-2-phenylindole, Sigma) nuclear
staining assay was performed. Cells were seeded on glass plate  a  80–90% onflu cy and treated 
with different concentrations of FAK-I (PF-562271: 0.1, 1, 10, 20, and 50 μM; and PF-573228: 0.1, 1, 10, 
20, and 50 μM) for 12 h. After completion of treatment, the cells were fix with m thanol for 10 min, 
washed twice with PBS, and incubated with DAPI solution for 10 min in th  d rk. Labeled cells we  
washed repeatedly with PBS to remove the excess DAPI stain a d evaluated under fl or scence 
microscope (Leica, Darmstadt, Germany). Quantification of ap ptotic cells was perf rmed by 
scoring 800–1000 cells from 10 different microscopic fields. R sult f  one of thr e dependent 
experiments is shown in figures. Values were compared to the control, and statistically signifi ant 
values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by two ast risks ( ). 
2.6. Cell Proliferation Assay 
The effect of FAK-inhibitor, CytD, resveratrol and their combina ion on the proliferation and 
viability of HCT116 and SW480 CRC cells was determ ned by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as d s ribed 
previously [36]. Briefly, the cells (5000 per well in triplicate in a 96-well plate) were treated w th 
either 5 μM resveratrol alone, different concentrations of CytD (0.1, 1, 2, a d 4 μg/mL), different 
concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 μM) each or co-treated with 5 μM resveratr l 
and the indicated concentrations of either CytD or FAK-I for 12 h. Subsequ ntly, 100 μL of modified 
cell culture medium (DMEM without phenol red, without ascorbic acid and ly 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was added to each well and the plate was incubated for 4 h at 37 °C. 
Finally, 100 μL of the MTT solubilization solution (10% Triton X-100/acidic isopropanol) was dded 
per well, and the cells incubated overnight at 37 °C. Metabolically act ve cells were evalua ed by 
measuring the Optical Density at 550 nm (OD550) using a 96-well multi-scanne  plat  ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data were deriv d fro  at le st three independent 
experiments, and statistical analysis was done to obtain the final values. 
2.7. Alginate Culture  
A detailed description of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) were resuspended in 
alginate (2% in 0.15 M NaCl) and added dropwise into a 100 mM CaCl2 solution a  ambie t 
temperature (AT) where the alginate beads polymerized after 10 min forming a round nd stable 
bead. Subsequently, the alginate beads were washed three times with 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion capacity, HCT116 and SW480 CRC cells we e cultured in alginate b ads 
as described above. Cells were either left untreated, or treated with 5 μM resveratrol alone, different 
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investigation, cells w re fixed with methanol, rinsed with PBS and incubated with bovine serum 
albumin (BSA) for 30 min. Primary antibodies w re diluted 1:50 in PBS/BSA, incubated overnigh  at 
4 °C in a humidfied chamber, washed three times with PBS/BSA f llowed by incubation with 
rhodamine-coupled secondary antibodies for 1.5 h and finally washed gain three times with aqua 
dest. Counter stai ing was performed with DAPI (4,6-diam d no-2-pheny indo e, Sigma) t  
visualize cell nuclei. Slides w re cov red with flu romount and examined u der a fluorescent 
microscope (Leica, Darmstadt, Germany). In FAK i mu ol bel d culture th  n mber f focal 
adhesion points was quantified by scoring 800–1 00 cells from 10 diff rent microscopic f elds. On  of
three ind pendent experiment  is shown. Values w re compared to the control, and sta stic lly 
significant values with p < 0.05 are designated by an asteri k ( ); p < 0.01 by two asteri ks ( ). 
2.5. DAPI Stai ing of A optotic Cells 
To examine the a optoti  changes induced by two diff rent FAK i hibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC cells, DAPI (4,6-diam dino-2-phen lindole, Sig a) nuc ear 
stai ing assay was performed. Cells w re se ed on glass plates at 80–90% fluency and treated 
with diff rent concentrations of FAK-I (PF-562271: 0. , 10, 20, and 50 μM; and PF-573228: 0. , 10, 
20, and 50 μM) for 12 h. After completion of treatment, th  cell w re fixed with me hanol for 10 min,
washed twice with PBS, and incubated with DAPI solution f r 10 i in th  dark. Labeled cells were 
washed r peatedly with PBS to remove th  excess DAPI sta n and evaluat d unde  fluorescence 
microscope (Leica, Darmstadt, Germany). Quantificatio  of a opto i  el s was performed by 
scoring 800–1 00 cells from 10 diff rent microscopic fi lds. Result from one of thre  ind p ndent 
experiment is shown in figures. Values w re compared to the control, and sta stically significant
values with p < 0.05 are designated by an aster sk ( ); p < 0.01 by two asteri ks ( ). 
2.6. Cell Proliferation Assay 
The ffect of FAK-inhibitor, CytD, resveratrol and their combination on the proliferatio  and 
viability of HCT116 and SW480 CRC cells was determined by t  
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described 
previously [36]. Briefly, the cells (5 00 per well in triplicate in a 96-well plate) w re treated with 
either 5 μM resveratrol alone, diff rent concentrations of CytD (0. , 1, 2, and 4 μg/mL), diff rent 
concentrations of FAK-I (PF-562271: 0.01, 0. 1, and 10 μM) each or co-treated with 5 μM resveratrol 
and the indicated concentrations of either CytD or FAK-I for 12 h. S bsequently, 100 μL of modified 
cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was ad ed to each well and the plate was incubated for 4 h at 37 °C. 
Finally, 100 μL of the MTT solubilization solution (10% Triton X-100/ac d c isopropanol) was a ed 
per well, and the cells incubated overnight at 37 °C. Metabolically active cells w r  evaluated by
measuring the Optical Density at 550 nm (OD550) using a 96-well multi-scanner plate ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data w re derived from at least three ind pendent 
experiments, and sta stic l nalysis was done to obtain the final values. 
2.7. Alginate C lture  
A detaile  description of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) w re re uspen ed in 
alginate (2% in 0.15 M NaCl) and ad e  dropwise into a 100 mM aCl2 solution at mbient
temperature (AT) wh re the alginate beads polymerized after 10 min forming a round and stable 
bead. Subsequently, the alginate beads w re washed three times ith 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion c pacity, HCT116 and SW480 CRC cell  w r  cultur d in alginate beads 
as described above. Cells w re either left untreated, o  treated with 5 μM resveratro  alone, diff rent 
).
3.6. esveratrol otentiates F -Inhibitor- and ytochalasin -Induced ctivation of aspase-3 in ells
fl resce ce icroscopy
exa ine the mechanisms by which resverat ol nd/or FAK-I or CytD inhibit cell viabil ty and
in uce apopto is of CRC cells, w analyzed nd compared thei effect on th rate of the ctivation
levels of caspase-3, which induces t e apopto ic pathway i cells [42,43]. T erefore, the am unt of
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apoptosis induced by resveratrol, FAK-I, CytD and their combined treatment in HCT116 (Figure 6I) was
confirmed by investigating the activation of caspase-3 with immunofluorescent labeling and induction
of morphological nuclear changes with DAPI nuclear staining (arrows) (Figure 6II). In untreated
control cultures of HCT116 (Figure 6I(A)) only small amounts of caspase-3 positive stained cells
(arrows) could be detected. In contrast to this, treatment with resveratrol, markedly induced caspase-3
expression in colorectal cancer cells (Figure 6I(B)). Interestingly, a significant increase of caspase-3 was
observed in the combined treatment of resveratrol with either FAK-I or CytD (Figure 6I(C,D)).
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Nuclear staining revealed that untreated control HCT116 (Figure 6II) cell cultures displayed an 
overall normal nuclear size with around 12% of apoptotic nuclei in the cell culture. In contrast, in 
cells treated with resveratrol, a significant increase of 59% apoptotic cells in HCT 16 with nucle r 
morphological changes such s pyknosis and chromatin condensation was observed. Significant 
dose-dependent i creases in apoptosis was observed in HCT116 treated with 10 μM FAK-I 
(PF-562271), with an apoptotic rate of 70%, a d with 0.1 μg/mL CytD, with an apoptotic rate of 56% 
(Figure 6II). Furth rmore, a sig ificant increase in fragmented nuclei and apoptotic features was 
observed by mbined treatment of resv ratrol a d either 10 μM FAK-I (51%) or 0.1 μg/mL CytD 
(94%) compar d to the treatment of nly resveratrol, FAK-I or CytD. 
 
Figure 6. Effects of resveratrol and/or specific FAK-inhibition and cytochalasin D on the apoptosis of 
CRC cells. (I) Serum-starved HCT116 cell lines in monolayer culture were either left untreated 
(IA,II), or were treated with 5 μM resveratrol alone (IB,II), 10 μM FAK-I (PF-562271) (II), 0.1 μg/mL 
CytD (II) or a combination of 5 μM resveratrol and either 10 μM FAK-I (PF-562271) (IC,II) or 0.1 
μg/mL CytD (ID,II) for 12 h. Immunofluorescent labeling with antibodies against caspase-3 followed 
by incubation with rhodamine-coupled secondary antibodies and counterstaining with DAPI to 
visualize cell nuclei. Images shown are representative of three different experiments; (II) 
Quantification of apoptotic cells was performed by scoring 800–1000 cells from 10 different 
microscopic fields. One of three independent experiments is shown. Values were compared to the 
control and statistically-significant values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by 
two asterisks ( ). Magnification 400×; bar = 30 nm.  
3.7. Resveratrol Potentiates FAK-Inhibitor- and Cytochalasin D-Inhibited Invasion of CRC Cells in 3D 
Alginate Tumor Microenvironment Culture 
To investigate the effect of resveratrol, FAK-I and CytD on cell motility and invasion capacity 
through the 3D tumor microenvironment, HCT116 and SW480 cells were cultured in an 
. tr l fi
cel s. (I) Serum-starved HCT116 cell lines in monolayer culture we either left untreated (IA,II),
or were treat d with 5 µM resveratrol alone (IB,II), 10 µM FAK-I (PF-562271) (II), 0.1 µg/mL CytD (II)
or a combination of 5 µM resveratrol and ither 10 µM FAK-I (PF-562271) (IC,II) or 0. µg/mL CytD
(ID,II) for 12 h. Immunofluorescent labeling with antibodies agai st caspase-3 followed by incubation
with rhod mi e-coupled seco dary antibodies and cou terstaining with DAPI to visualize cell nuclei.
Images shown are representative of three differ nt experim nts; (II) Quantification of apoptotic cells
was performed by scoring 800–1000 cells from 10 different microscopic fields. One of three independe t
experiments is shown. Values were compared to the control and statistically-significant values with
p < 0.05 are designated by an asterisk (
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investigation, cells were fixed with methanol, rinsed with PBS and incubated with bovine serum 
albumin (BSA) for 30 min. Primary antibodies were diluted 1:50 in PBS/BSA, incubated overnight at 
4 °C in a humidfied chamber, washed three times with PBS/BSA followed by incubation with 
rhodamine-coupled secondary antibodies for 1.5 h and finally washed again three times with aqua 
dest. Counter staining was performed with DAPI (4,6-diamidino-2-phenylindole, Sigma) to 
visualize cell nuclei. Slides were covered with fluoromount and examined under a fluorescent 
microscope (Leica, Darmst dt, Germany). In FAK immunolabeled cultures the number of focal 
adhesion points was quantified by scoring 800–10  cells from 10 different microscopic fi . ne of 
three independent experiments is hown. Values were red to the control, and st tistically 
significant values with p < 0.05 are designated by an asteris  ( ); p < 0.01 by two asterisks ( ). 
2.5. DAPI Staining of Apoptotic Cells 
To examine the apoptotic changes induced by two different FAK inhibitors (PF-562271 and 
PF-573228) in HCT116 and SW480 CRC cells, DAPI (4,6-diamidino-2-phenylindole, Sigma) nuclear 
staining assay was performed. Cells were s eded n glass plates at 80–90% confluen y and reated 
with different concentrations of FAK-I (PF-562271: 0.1, 1, 10, 20, and 50 μM; and PF-573228: 0.1, 1, 10, 
20, and 50 μM) for 12 h. After completion of treatment, the cells were fixed with methanol for 10 min, 
washed twice with PBS, and incubated with DAPI solution for 10 min in the dark. Labeled cells were 
washed repeatedly with PBS to remove the excess DAPI stain and evaluated under fluorescence 
microscope (Leica, Darmstadt, Germany). Quantification of apoptotic cells was performed by 
scoring 800–1000 cells from 10 different microscopic fields. Result from one of three independent 
experiments is shown in figures. Values were compared to the control, and statistically significant 
values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by two asterisks ( ). 
2.6. Cell Proliferation Assay 
The effect of FAK-inhibitor, CytD, resveratrol and their combination on the proliferation and 
viability of HCT116 and SW480 CRC cells was determined by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described 
previously [36]. Briefly, the cells (5000 per well in triplicate in a 96-well plate) were treated with 
either 5 μM resveratrol alone, different concentrations of CytD (0.1, 1, 2, and 4 μg/mL), different 
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Apoptosis induction by caspase-3 activation was confirmed by examining morphological nuclear
changes indicative of apoptosis with DAPI nuclear staining (Figure 6II). The number of apoptotic
nuclei was quantified by scoring 800–1000 cells from 10 different microscopic fields. Nuclear staining
revealed that untreated control HCT116 (Figure 6II) cell cultures displayed an overall normal nuclear
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size with around 12% of apoptotic nuclei in the cell culture. In contrast, in cells treated with resveratrol,
a significant increase of 59% apoptotic cells in HCT116 with nuclear morphological changes such as
pyknosis and chromatin condensation was observed. Significant dose-dependent increases in apoptosis
was observed in HCT116 treated with 10 µM FAK-I (PF-562271), with an apoptotic rate of 70%, and with
0.1 µg/mL CytD, with an apoptotic rate of 56% (Figure 6II). Furthermore, a significant increase in
fragmented nuclei and apoptotic features was observed by combined treatment of resveratrol and
either 10 µM FAK-I (51%) or 0.1 µg/mL CytD (94%) compared to the treatment of only resveratrol,
FAK-I or CytD.
3.7. Resveratrol Potentiates FAK-Inhibitor- and Cytochalasin D-Inhibited Invasion of CRC Cells in 3D Alginate
Tumor Microenvironment Culture
To investigate the effect of resveratrol, FAK-I and CytD on cell motility and invasion capacity
through the 3D tumor microenvironment, HCT116 and SW480 cells were cultured in an alginate-based
tumor microenvironment, treated as described in detail in material and methods and the capacity of
migration and invasion was determined through the evaluation of the colony formation with toluidine
blue staining after 10 days (Figure 7).
As shown in Figure 7, treatment of the CRC cells (HCT116 and SW480) with resveratrol (5 µM)
alone significantly blocked (p < 0.05) the migration rate of HCT116 (Figure 7A,B-D,E) and SW480
(Figure 7A,C-D,F) cells through the alginate-based matrix after an incubation time of 28 days by
82% and 83%, respectively, compared to untreated cells. Treatment of CRC cells with CytD at 0.1,
1, and 2 µg/mL inhibited the migration of HCT116 through the alginate matrix by 42%, 68.2% and
95.5%, respectively (Figure 7A,B), and of SW480 (Figure 7A,C) by 51%, 73.6% and 86.4%, respectively.
Additionally, the combined treatment of resveratrol (5 µM) and CytD (0.1, 1, and 2 µg/mL) was much
more effective in comparison to the individual compound, enhancing invasion-inhibition ability of
HCT116 to 91%, 98.2% and 99.1%, respectively (Figure 7A,B), and of SW480 to 89%, 91% and 97.3%,
respectively (Figure 7A,C).
The treatment of CRC cells with FAK-I (PF-562271) (0.1, 1, 10 µM) inhibited migration of HCT116
through the alginate matrix by 22%, 58% and 88%, respectively (Figure 7D,E) and of SW480 by 49.5%,
72% and 96%, respectively (Figure 7D,F). Additionally, the combined treatment of resveratrol and
FAK-I (0.1, 1, and 10 µM) was more effective than in individual treatment, as the invasion-inhibition
ability was enhanced in HCT116 to 85%, 99.6% and 99.8%, respectively (Figure 7D,E), and in SW480 to
88.5%, 98% and 99.5%, respectively (Figure 7D,F).
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Figure 7. Effects of resveratrol and/or specific FAK-inhibition and cytochalasin D on the migration of
CRC cells in alginate culture. (A–C) Serum-starved HCT116 and SW480 cell lines in alginate beads
(1 × 106) were either left untreated or treated with 5 µM resveratrol alone, different concentrations of
CytD (0.1, 1, and 2 µg/mL) or co-treated with 5 µM resveratrol and the indicated concentrations of
CytD and emigrated spheroids evaluated by toluidine blue staining after 28 days; (D–F) Serum-starved
HCT116 and SW480 cell lines in alginate beads (1 × 106) were either left untreated or treated with
5 µM resveratrol alone, different concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, 10 µM) or co-treated
with 5 µM resveratrol and the indicated concentrations of FAK-I and emigrated spheroids evaluated by
toluidine blue staining after 28 days. The values given are the means ± standard errors of the mean
of three replicates. One of three independent experiments is shown. Values were compared with the
control and statistically significant values with p < 0.05 are designated by an asterisk (
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investigation, cells were fixed with methanol, rinsed with PBS and incubated with bovine serum 
albumin (BSA) for 30 min. Primary antibodies were diluted 1:50 in PBS/BSA, incubated overnight at 
4 °C in a humidfied chamber, washed three times with PBS/BSA followed by incubation with 
rhodamine-coupled secondary antibodies for 1.5 h and finally washed again three times with aqua 
dest. Counter staining was performed with DAPI (4,6-diamidino-2-phenylindole, Sigma) to 
visualize cell nuclei. Slides were covered with fluoromount and examined under a fluorescent 
microscope (Leica, Darmst dt, Germany). In FAK immunolabeled cultures the number of focal 
adhesion points was qu ntified by scoring 800–1000 cells from 10 diff rent microscopic fields. One of 
three indep ndent experiments is hown. Values were red to the control, and statistically 
significa t v lues with p < 0.05 are d signated by an asterisk ( ); p < 0.01 by two asterisks ( ). 
2.5. DAPI Staining of Apoptotic Cells 
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with different concentrations of FAK-I (PF-562271: 0.1, 1, 10, 20, and 50 μM; and PF-573228: 0.1, 1, 10, 
20, and 50 μM) for 12 h. After completion of treatment, the cells were fixed with methanol for 10 min, 
washed twice with PBS, and incubated with DAPI solution for 10 min in the dark. Labeled cells were 
washed repeatedly with PBS to remove the excess DAPI stain and evaluated under fluorescence 
microscope (Leica, Darmstadt, Germany). Quantification of apoptotic cells was performed by 
scoring 800–1000 cells from 10 different microscopic fields. Result from one of three independent 
experiments is shown in figures. Values were compared to the control, and statistically significant 
values with p < 0.05 are designated by an asterisk ( ); p < 0.01 by two asterisks ( ). 
2.6. Cell Proliferation Assay 
The effect of FAK-inhibitor, CytD, resveratrol and their combination on the proliferation and 
viability of HCT116 and SW480 CRC cells was determined by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described 
previously [36]. Briefly, the cells (5000 per well in triplicate in a 96-well plate) were treated with 
either 5 μM resveratrol alone, different concentrations of CytD (0.1, 1, 2, and 4 μg/mL), different 
concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, and 10 μM) each or co-treated with 5 μM resveratrol 
and the indicated concentrations of either CytD or FAK-I for 12 h. Subsequently, 100 μL of modified 
cell culture medium (DMEM without phenol red, without ascorbic acid and only 3% FBS) and 10 μL 
MTT solution (5 mg/mL) was added to each well and the plate was incubated for 4 h at 37 °C. 
Finally, 100 μL of the MTT solubilization solution (10% Triton X-100/acidic isopropanol) was added 
per well, and the cells incubated overnight at 37 °C. Metabolically active cells were evaluated by 
measuring the Optical Density at 550 nm (OD550) using a 96-well multi-scanner plate ELISA reader 
(Bio-Rad Laboratories Inc. Munich, Germany). Data were derived from at least three independent 
experiments, and statistical analysis was done to obtain the final values. 
2.7. Alginate Culture  
A detailed description of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) were resuspended in 
alginate (2% in 0.15 M NaCl) and added dropwise into a 100 mM CaCl2 solution at ambient 
temperature (AT) where the alginate beads polymerized after 10 min forming a round and stable 
bead. Subsequently, the alginate beads were washed three times with 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
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To investigate invasion capacity, HCT116 and SW480 CRC cells were cultured in alginate beads 
as described above. Cells were either left untreated, or treated with 5 μM resveratrol alone, different 
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(Bio-Rad Laboratories Inc. Munich, Germany). Data w re derived from at least three ind pendent 
experiments, and sta stic l nalysis was done to obtain the final values. 
2.7. Alginate C lture  
A detaile  description of cell cultivation in alginate culture has been previously described by 
our group [26,30,37]. Briefly, HCT116 and SW480 CRC cells (1 × 106/mL) w re re uspen ed in 
alginate (2% in 0.15 M NaCl) and ad e  dropwise into a 100 mM aCl2 solution at mbient
temperature (AT) wh re the alginate beads polymerized after 10 min forming a round and stable 
bead. Subsequently, the alginate beads w re washed three times ith 0.15 M NaCl solution and 
twice with serum-starved medium (3% FBS) before starting treatment.  
2.8. Invasion (Migration) Assay  
To investigate invasion c pacity, HCT116 and SW480 CRC cell  w re cultur d in alginate beads 
as described above. Cells w re either left untreated, o  treated with 5 μM resveratro  alone, diff rent 
).
3.8. Resveratrol-Mediated Anti-Tumorigenic Effects Are Potentiated by Inhibition of FAK and
Cytoskeletal Proteins
Next, to investigate the u derlying mech nism of FAK signaling and cytoskeletal organization
on th resveratrol-induce anti- arci og ic effects in colorectal cancer cells, immu oblotting was
performed. HCT116 (Figure 8) cells were cultured in tumor microenvironment alginate beads as
d scribed in materials and m thods and either left untreated, or were treated with 5 µM resveratrol
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alone, 0.1 µg/mL CytD, 10 µM FAK-I (PF-562271) or co-treated with 5 µM resveratrol and either the
indicated concentration of CytD or FAK-I for 10 days.
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Serum-starved HCT116 and SW480 cell lines in alginate beads (1 × 106) were either left untreated or 
treated with 5 μM resveratrol alone, different concentrations of FAK-I (PF-562271: 0.01, 0.1, 1, 10 μM) 
or co-treated with 5 μM resveratrol and the indicated concentrations of FAK-I and emigrated 
spheroids evaluated by toluidine blue staining after 28 days. The values given are the means ± 
standard errors of the mean of three replicates. One of three independent experiments is shown. 
Values were compared with the control and statistically significant values with p < 0.05 are 
designated by an asterisk ( ); p < 0.01 by two asterisks ( ). 
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Figure 8. Effects of resveratrol and/or specific FAK-inhibitor and cytochalasin D on Sirt1; adhesion, 
proliferation, invasion, and metastatic gene products; and NF-κB signaling pathway in CRC cells. 
Serum-starved HCT116 cell line in alginate beads (1 × 106) were either left untreated or treated with: 5 
μM resveratrol alone or 0.1 μg/mL CytD (A,B); 10 μM FAK-I (PF-562271) (C,D); or co-treated with 5 
μM resveratrol and either the indicated concentration of: CytD (A,B); or FAK-I (C,D) for 10 days. 
Whole cell lysates were fractionated and analyzed by Western blotting using antibodies against: 
Sirt1, Ki-67, β1-integrin, FAK, and p-FAK (A,C); and p-NF-κB-65/50, MMP-9, MMP-13, CXCR4, and 
caspase-3 (B,D). Western blots shown are representative of three independent experiments. The 
housekeeping protein β-actin served as a positive loading control in all experiments. 
Figure 8. Effects of resveratrol and/or specific FAK-inhibitor and cytochalasin D on Sirt1; adhesion,
proliferation, invasion, and etastatic gene products; and F-κB signaling path ay in CRC cells.
Seru -starved CT116 cell line in alginate beads (1 × 106) were either left untreated or treated
with: 5 µM resveratrol alone or 0.1 µg/mL CytD (A,B); 10 µM FAK-I (PF-562271) (C,D); or co-treated
with 5 µM resveratrol and either the indicated concentration of: CytD (A,B); or FAK-I (C,D) for
10 days. Whole cell lysates were fractionated and analyzed by Western blotting using antibodies
against: Sirt1, Ki-67, β1-integrin, FAK, and p-FAK (A,C); and p-NF-κB-65/50, MMP-9, MMP-13,
CXCR4, and caspase-3 (B,D). Western blots shown are representative of three i ependent experiments.
The housekeeping protein β-actin served as a positive loading c ntrol in all experiments.
3.9. Resveratrol-Mediated Sirt1 Up-Regulation Is Suppressed by FAK Inhibitor or by Cytochalasin D
First, we investigated whether resveratrol-induced up-regulation of Sirt1 expression and the
associated anti-proliferative effects in CRC cells are dependent on FAK and/or cytoskeletal signaling
proteins. Total protein lysates were subjected to immunolabeling with Sirt1 and Ki67 antibodies
(Figure 8A,C). As demonstrated by Western blot analysis, treatment with resveratrol up-regulated the
expression of Sirt1 protein and significantly suppressed Ki67 compared to untreated cultures.
Destabilization of actin cytoskeleton by CytD or by inhibition of FAK with FAK
inhibitor (PF-562271) markedly suppressed resveratrol-induced Sirt1 up-regulation in HCT116.
Further, marked Ki67 suppression was observed in CytD, FAK-I or the combinational treatment
(Figure 8A,C). These results highlight that, at least in part, FAK has a functional role in
resveratrol-Sirt1-mediated anti-tumorigenic signaling in CRC cells.
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3.10. Resveratrol-Induced Suppression of β1-Integrin and FAK Is Potentiated by FAK Inhibition and
Cytochalasin D
It has been shown that FAK participates in integrin mediated signaling functions, thereby enabling
cell adhesion signals which stimulate reorganization of the cytoskeleton [11,12], and resveratrol has
been shown to decrease the levels of β1-integrins and inhibit phosphorylation of FAK in several
cancer cell lines [32–35]. Therefore next, we investigated the effect of resveratrol on Integrin
and FAK activation in CRC cells. HCT116 cells were treated as described above and Western
blotting performed with Integrin, FAK and p-FAK antibodies (Figure 8A,C). As demonstrated in
Figure 8, resveratrol treatment markedly suppressed Integrin expression and activation of FAK in
CRC cells compared to untreated controls (Figure 8A,C). Further, treatment with CytD alone or in
combination with resveratrol had a suppressive effect on Integrin expression and activation of FAK.
Interestingly, marked down-regulation of Integrin expression and FAK phosphorylation was observed
in individual treatment with CytD or FAK-I or in co-treatment with resveratrol, but had no such
effect on basal, inactivated FAK levels. Taken together, these results support a functional role for
Integrin-FAK-mediated signaling and cytoskeletal signaling proteins as target proteins, at least in part
of resveratrol mediated anti-tumorigenic effects in CRC cells.
3.11. Resveratrol-Potentiates FAK-Inhibitor- and Cytochalasin D-Induced Suppression of NF-κB Activation in
CRC Cells
It has been previously shown that resveratrol has a functional role in suppression of
the NF-κB signaling pathway in CRC cells [26]. To elucidate whether suppression of NF-κB
signaling by resveratrol is modulated by FAK activity or cytoskeletal signaling proteins, HCT116
and SW480 cells were treated as described above and immunoblotting was performed with
anti-NF-κB-p50 and anti-NF-κB-p65 (Figure 8B,D). Immunoblotting analysis demonstrated that
resveratrol treatment significantly suppressed activation of NF-κB compared to control cultures
(Figure 8B,D). Further, phosphorylation of NF-κB subunits (p50/p65) was markedly suppressed by
CytD or FAK inhibition in HCT116 (Figure 8B,D). Interestingly, a synergistic effect on suppression
of NF-κB activation was observed in the combination treatment with either CytD or FAK inhibitor.
Overall, these results indicate that resveratrol-induced suppression of NF-κB activation is at least in
part dependent on FAK and cytoskeletal signaling proteins.
3.12. Resveratrol-Potentiates FAK-Inhibitor- and Cytochalasin D- Induced Suppression of NF-κB-Dependent
Gene End Products Involved in Invasion, Metastasis and Apoptosis
To further characterize the role of FAK and cytoskeletal signaling proteins on resveratrol-mediated
suppression of malignancy and metastatic ability in HCT116 cells, protein expression of tumor
metastasis associated promoting factors influencing tumor cell invasion, metastasis and apoptosis
were investigated. CRC cells were treated as described above and Western blotting was performed for
anti-MMP-9, -MMP-13, -CXCR4 and -cleaved-caspase-3 (Figure 8B,D). Compared to untreated control
cultures resveratrol significantly suppressed MMP-9, MMP-13 and CXCR4 and markedly up-regulated
activated Caspase-3 in CRC cells (not shown). Interestingly, these effects were significantly stronger in
resveratrol mono-treatment compared to CytD, FAK-I or the combinational treatment. These results
highlight that resveratrol-induced suppression of malignancy, metastatic ability and induction of
apoptosis in CRC cells is, at least in part, mediated by FAK and cytoskeleton signaling proteins.
4. Discussion
Our data reveal that resveratrol indeed suppresses CRC proliferation and invasion by
up-regulation of Sirt1 activity, inhibition of NF-κB-mediated inflammatory pathway and suppression
of focal adhesion kinase (FAK) activity, resulting in a loss of focal adhesion molecules, a planar surface
of the CRC cells and an increase in apoptosis.
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Despite major advances in oncology, colorectal cancer (CRC) remains one of the major causes
of cancer-related morbidity and mortality worldwide [1]. Although treatment options range from
radiotherapy, surgery and chemotherapy to combination treatment, chemotherapy still offers the
best chance to prevent invasion and metastasis. However, most chemotherapies fail to effectively
combat metastatic cancer and have high prevalence of recurrence, chemoresistance and are toxic
and expensive.
Therefore, new pharmacologically effective and safe therapeutic approaches that may
prevent the initial invasion of cancer cells from primary tumors and thus prevent metastasis
are urgently sought. Natural compounds such as resveratrol have gained much attention for
preventive and therapeutic strategies in cancer treatment including colorectal cancer [44,45].
Resveratrol (3,5,4′-trihydroxy-trans-stilbene), found in more than 70 plant species, has shown to exhibit
both chemopreventive and chemotherapeutic potential [20–22]. We have shown in this study that
resveratrol indeed altered the cell phenotype of two CRC cell lines HCT116 and SW480, by inducing
cell cluster formation, encouraging cell attachment and reducing cell viability. Indeed, in a study from
our own laboratory we could previously show that resveratrol affects multiple cell adhesion molecules,
desmosomes, tight, gap junctions and signaling molecules involved in cell proliferation, invasion and
metastasis [26].
Further, we found that treatment of the CRC cell lines with an inhibitor to FAK or with CytD
markedly promoted cellular attachment and rather more cell clusters were observed. Indeed, it has
been previously shown that cancer cell invasion (migration) is an essential initial step of spontaneous
carcinogenesis and metastasis and to understand more detailed this important mechanism may be
useful for the treatment/prevention of CRC. Focal adhesion kinase (FAK) is an intracellular tyrosine
kinase that regulates cellular adhesion, control of cell-extracellular interactions such as cell spreading,
migration, metastasis, motility, cancer stem cell self-renewal and survival in many types of cancers and
FAK is overexpressed in a number of tumors including CRC [18]. As FAK is a non-receptor tyrosine
kinase that is activated in response to cell adhesion and transduces extracellular signals through
tyrosine phosphorylation onto various intracellular molecules in both growth factor dependent and
adhesion-dependent manner, it is fundamentally involved in modulating cancer progression and
metastasis [8]. Interestingly, in several cancers, including breast and ovarian carcinomas, genetic tumor
profiling has revealed both FAK DNA amplification (PTK2 gene at 8q24.3) and elevated FAK mRNA
levels [19]. Indeed, activation of FAK has been shown to be high in metastatic aggressive tumors and
is correlated with poor clinical outcome [8].
Cytochalasins are a class of fungal metabolites affecting a wide variety of motile functions
of eukaryotic cells [46]. CytD has been described to de-stabilize, disorganize and alter the actin
cytoskeleton [47,48]. Here we could demonstrate that FAK inhibition and CytD additionally
dose-dependently reduced CRC HCT116 and SW480 cell viability, induced cell cluster formation and
encouraged cell attachment similar to resveratrol treatment. Indeed, it has been previously shown that
resveratrol or FAK-inhibition suppresses cancer cell viability and survival [8,26,30,41]. These observed
effects of resveratrol, FAK- inhibition and CytD in HCT116 and SW480 CRC cells highlight the
involvement of cytoskeletal signaling molecules in resveratrol-mediated anti-tumorigenic effects.
We have further shown that resveratrol up-regulates Sirt1 expression and suppresses FAK
expression in HCT116 and SW480 CRC cells. It has been previously suggested that resveratrol
acts as a multi-targeted agent in cancer as it modulates several cellular signaling pathways involved
in cancer cell survival, proliferation and metastasis [23–26]. Indeed, it has been previously shown
that the nucleus related NAD+ histone deacetylase class III sirtuin 1 (Sirt1), is a major target for
resveratrol [40]. Resveratrol provokes a structural conformational change in Sirt1, consequently
resulting in an increased enzymatic activity [40]. Moreover, we could demonstrate previously that
resveratrol-induced Sirt1 up-regulation is required for the resveratrol-mediated chemopreventive
effects in colorectal cancer cells [30]. Further, combinational treatment of resveratrol with FAK-I
or CytD suppressed resveratrol-induced Sirt1 activation and FAK. Interestingly, it has been shown
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that deletion of Sirt1 in bone marrow macrophages (BMMs) increased expression and acetylation
of FAK, as well as NF-κB [49]. This highlights a potential role for FAK-Sirt1 signaling pathway in
resveratrol-mediated anti-tumorigenic effects of resveratrol in CRC cells.
It has been previously described that inhibition of FAK impairs cancer development in preclinical
and clinical trials [8]. Indeed, in our study, we could demonstrate a marked dose-dependent effect
of specific FAK inhibitors (PF-562271 or PF-573228) on growth inhibition and induction of apoptosis
in HCT116 and SW480 CRC cells. Both specific FAK inhibitors are ATP-competitive, reversible
inhibitors of FAK. Indeed, it has been recently shown that inhibition of FAK, with specific FAK
inhibitors, enhances chemosensitivity and suppresses invasion of cancer cells such as lung and breast
carcinoma [50,51]. This underlines the important aspect of active FAK-signaling for the interaction
between the CRC cells and their surrounding tumor microenvironment to control and regulate cancer
progression and metastasis. It is well known that activation of caspase-3 induces the apoptotic
pathway in cells [42,43]. We further demonstrated that indeed resveratrol alone activated caspase-3 and
potentiated nuclear signs of apoptosis in CRC cells and this was markedly enhanced by combinational
treatment of resveratrol with FAK-I or CytD. Furthermore, here we assessed a potential relationship
between resveratrol and FAK-signaling pathway and investigated the combined potential to enhance
and stimulate apoptosis in CRC cells. Interestingly, it has been recently shown that inhibition of FAK
and CXCR4 and simultaneous treatment of lung carcinoma cells with doxorubicin potentiated their
anti-tumorigenic effects [51]. These results highlight that FAK and cytoskeletal signaling molecules
are, at least in part, one of the main target proteins for resveratrol-mediated anti-tumorigenic effects in
CRC cells.
Several reports from our and other laboratories have reported that three dimensional culture
models provide excellent in vitro culture conditions compared to two dimensional models, as they
more adequately represent physiological conditions that exist in vivo [37,52,53] Indeed, recent reports
from our laboratory have shown that alginate bead culture provides an excellent tumor
microenvironment were the CRC cells can proliferate, form spheroids, migrate through the alginate
matrix and finally form metastases [30,37]. Our data in this study indicate that resveratrol suppressed
invasion (migration) and colony forming capacity of HCT116 and SW480 CRC cells in alginate bead
tumor microenvironment culture, similar to FAK inhibitor or CytD. This is consistent with previous
reports, which showed that resveratrol inhibits angiogenesis, proliferation and metastasis in different
kinds of tumors [54–56]. Additionally, the anti-invasive and anti-metastases effect of resveratrol
was potentiated in the combinational treatment of FAK-I and CytD. Cytoskeleton reorganization
and remodeling is a critical step for cancer cell invasion and metastasis. In line with our results,
FAK inhibition in a murine model with PF-562271 resulted in decreased tumor cell proliferation,
migration and tumor-associated macrophages and fibroblasts [57]. The data presented here now
underline the importance of participation of FAK and cytoskeletal signaling proteins in resveratrol
mediated anti-invasive and anti-metastasis properties in CRC cells.
Further, we also found in alginate tumor microenvironment cultures of CRC cells that
resveratrol-induced up-regulation of Sirt1, blocked CRC cell proliferation and concomitantly
suppressed Integrin and activation of FAK. In contrast to this, FAK inhibitor or CytD alone did
not up-regulate Sirt1 expression, but merely suppressed Integrin expression and activation of FAK.
Resveratrol has been previously shown to suppress migration of cancer cells by modulation of
integrin activity [31] and to decrease the levels of cell adhesion proteins and suppress expression
of epithelial-to-mesenchymal-transition associated mediators α5β1 integrins and hyaluronic acid in
ovarian cancer cell lines [32]. Interestingly, resveratrol has been further shown to decrease the levels of
β1-integrins and at the same time inhibit phosphorylation of FAK in several cancer cell lines [32–35].
Further, it has been shown that FAK participates in integrin-mediated signaling functions, thereby
enabling cell adhesion signals that stimulate reorganization of the cytoskeleton [11,12]. Indeed, it has
been suggested that overexpression of β4-Integrins and FAK in colorectal cancer lead to subsequent
FAK activation, essential for early steps of tumorigenesis [58].
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Furthermore, we also found that resveratrol, FAK-I or CytD inhibited activation of NF-κB,
suppressing NF-κB–dependent gene end-products involved in invasion (MMPs), metastasis (CXCR4)
and activating those involved in apoptosis (cleavage of caspase-3). Interestingly, these observed effects
of resveratrol were significantly potentiated by combinational treatment with either FAK-I or CytD.
It has been previously reported that resveratrol inhibits IκB-kinase-β-mediated NF-κB activation
and it is a potent natural activator of Sirt1 [27–29]. Indeed, in CRC cells, resveratrol-induced Sirt1
has a functional role in inhibiting activation of the NF-κB signaling pathway [26,30], wereby Sirt1
deacetylates the NF-κB-p65 subunit and thus attenuates NF-κB-mediated gene transcription and
inflammation pathways [59]. Further, it has been shown that deletion of Sirt1 increased expression
and acetylation of FAK, as well as NF-κB [49]. Moreover, it has been observed that FAK, besides its
canonical roles as a cytoplasmic kinase downstream of integrin and growth factor receptor signaling,
can also serve as a co-transcriptional regulator that alters a gene transcriptional activity by shuttling
from focal adhesions to the nucleus to directly convey extracellular signals [60]. Further, FAK contains
NF-κB and p53 binding sites, which regulate induction and inhibition of FAK transcription [61].
Transcription of FAK is regulated by binding of NF-κB to the Ptk2 gene promoter and activation of
NF-κB by TNF-α increases FAK transcriptional activation [61]. These results highlight the potential
pharmacological use of resveratrol-induced Sirt1 pathway in targeting FAK and NF-κB in chronic
inflammatory diseases including cancer.
5. Conclusions
In conclusion, for the first time, we describe herein that the anti-cancerogenic mechanism of
resveratrol is mediated, at least partially, by the inhibition of FAK in CRC cells. This results in
suppression of early steps of cancerogenesis, with increased apoptosis and suppression of migration
and metastasis in cancer cells (Figure 9). In addition, we could further demonstrate that FAK-inhibition
suppresses resveratrol-induced Sirt1 activation. As Sirt1 is an important molecular target of resveratrol,
it seems that the anti-cancerogenic effect induced by resveratrol-Sirt1-activation in CRC cells is
mediated at least in part by the FAK signaling pathway. Indeed, it has been reported that resveratrol is
apparently rapidly metabolized in vivo [62]. Although further investigations are needed to understand
more on the signaling mechanism of resveratrol, our findings suggest that a molecular signaling
pathway relationship between resveratrol-induced Sirt1 and FAK activation, which might be a novel
therapeutic target for crucial regulation of cell proliferation, migration and metastases in colon cancer.Nutrients 2017, 9, 1073 18 of 21 
 
 
Figure 9. Schematic diagram shows resveratrol-mediated antitumor activity by modulation of focal 
adhesion kinase in colorectal cancer cells. 
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